3 more cats treated for VCA study after first 2 showed "confirming objective response (destruction of tumor tissue) without any negative or detrimental side-effects."
The Company currently is outsourcing material aspects of manufacturing of its product in the United States and intends to enter into licensing arrangements outside of the United States for the manufacturing and distribution of RadioGelTM in other countries.
News 
Market Data 
Discover 
